The Calderdale Royal Hospital is a hospital situated in the English town of Halifax. It is located in the suburb of Salterhebble and provides general services, emergency services and some specialist services. It is managed by Calderdale and Huddersfield NHS Foundation Trust.

During the past decade, Calderdale Royal Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Calderdale Royal Hospital" #1 sponsor was "University Hospital Southampton NHS Foundation Trust" with 2 trials, followed by "University of Leeds" with 2 trials sponsored, "University of Oxford" with 2 trials sponsored, "Cardiff University" with 1 trials sponsored and "DePuy International" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Calderdale Royal Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Barts and the London School of Medicine and Dentistry" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Calderdale Royal Hospital" are "Multiple Myeloma" (2 trials), "Atrial Fibrillation" (1 trials), "Atrial Flutter" (1 trials), "Bladder Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Calderdale Royal Hospital" in a lesser frequency.

Most popular intervention types in "Calderdale Royal Hospital" are "Drug" (12 trials), "Other" (3 trials), "Procedure" (2 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.5 mg ranibizumab" (1 trials), "AZD2014" (1 trials), "Acenocoumarol" (1 trials), "Apixaban" (1 trials) and "Augmented autologous stem cell transplant (ASCT-aug)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Calderdale Royal Hospital" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Calderdale Royal Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Calderdale Royal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Calderdale Royal Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".